Exact Mass: 400.2297
Exact Mass Matches: 400.2297
Found 500 metabolites which its exact mass value is equals to given mass value 400.2297
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cincassiol B
Constituent of Cinnamomum cassia (Chinese cinnamon) [CCD]. Cincassiol B is found in chinese cinnamon and herbs and spices. Cincassiol B is found in chinese cinnamon. Cincassiol B is a constituent of Cinnamomum cassia (Chinese cinnamon).
Marinobufagin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D004791 - Enzyme Inhibitors
Nevskin
Constituent of Ferula assa-foetida (asafoetida). Nevskin is found in herbs and spices and green vegetables. Nevskin is found in green vegetables. Nevskin is a constituent of Ferula assa-foetida (asafoetida)
Lucidone B
Lucidone B is found in mushrooms. Lucidone B is from Ganoderma lucidum (reishi
5alpha-Pregnan-3beta,20beta-diol 3-sulfate
5alpha-Pregnan-3beta,20beta-diol 3-sulfate, also known as 5α-pregnan-3β,20β-diol sulfate, belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3beta,20beta-diol 3-sulfate has been identified in the human placenta (PMID: 32033212).
5alpha-Pregnan-3beta,20beta-diol 20-sulfate
5alpha-Pregnan-3beta,20beta-diol 20-sulfate, also known as 5α-pregnan-3β,20β-diol sulfate, belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3beta,20beta-diol 20-sulfate has been identified in the human placenta (PMID: 32033212).
Marinobufagenin
Nocloprost
MG(5-iso PGF2VI/0:0/0:0)
MG(5-iso PGF2VI/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/5-iso PGF2VI/0:0)
MG(0:0/5-iso PGF2VI/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
[1R-[1alpha(E),2alpha,4abeta,5beta,7alpha]]-1,2,3,4,4a,5,6,7-Octahydro-7-hydroperoxy-5-hydroxy-4a,8-dimethyl-2-(1-methylethyl)-1-naphthalenyl ester 3-phenyl-2-propenoic acid
[1R-[1alpha(E),2alpha,4abeta,5beta,8alpha,8aalpha]]- 1,2,3,4,4a,5,8,8a-Octahydro-8-hydroperoxy-5-hydroxy-4a,8-dimethyl-2-(1-methylethyl)-1-naphthalenyl ester 3-phenyl-2-propenoic acid
2,16-dihydroxy-22,23,24,25,26,27-hexanorcucurbit-5-ene-11,20-dione|Hexanorcucurbitacin I
10-O-beta-D-glucopyranosideoplopanone|oplopanone-8-O-beta-D-glucopyranoside
1-O-isopropyl-6-O-(5,9-dimethyl-2,8-decadienoyl)-beta-D-glucopyranoside|citrusoside A
3,4-dihydroxy-16-methoxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid|Desacetylvindolin
(20S,22S,23R,24S)-14beta,22:22,25-diepoxy-5-methoxy-des-A-ergosta-5,7,9,11-tetraene-19,23-diol|blazeispirol E
8-O-(p-coumaroyl)-5beta-hydroperoxy-1(10)E,4(15)-humuladien-8alpha-ol
(4aS)-8t-Hydroxy-1t-sulfooxy-2c.10at.12at-trimethyl-(4arH.4btH.6acH.10bcH)-octadecahydro-chrysen|17abeta-Sulfooxy-17alpha-methyl-D-homo-5alpha-androstanol-(3beta)|Schwefelsaeure-mono-(3beta-hydroxy-17alpha-methyl-D-homo-5alpha-androstanyl-(17abeta)-ester)|sulfuric acid mono-(3beta-hydroxy-17alpha-methyl-D-homo-5alpha-androstanyl-(17abeta)-ester)
1(R),4beta-dihydroxy-trans-eudesm-6-ene-1-O-beta-D-glucopyranoside
3beta,11-dihydroxy-drim-8(12)-en-11-O-beta-D-glucopyranoside|xianglinmaojueside A
4beta-cinnamoyloxy-7alpha-hydroperoxy-1beta-hydroxyeudesm-8-ene
7-Methyl-3-methylene-6-octen-1-ol-O-beta-D-(2,6-O-diacetylglucopyranoside)|7-Methyl-3-methylene-6-octen-1-ol-O-beta-D-<2,6-O-diacetylglucopyranoside>
7-oxo-8,11,13-abietatriene-18-succinic acid|abiesadine Q
3beta-[(beta-D-glucopyranosyl)oxy]eudesm-4(14)-en-11-ol
(3aR,4aR,5R,6S,9aS)-2,3,3a,4,4a,5,6,9a-octahydro-3a,9a-dihydroxy-4a,5-dimethyl-3-methylidenenaphto<2,3-b>furan-6-yl (6S,2E,4E)-6-methylocta-2,4-dienoate|(3aR,4aR,5R,6S,9aS)-2,3,3a,4,4a,5,6,9a-octahydro-3a,9a-dihydroxy-4a,5-dimethyl-3-methylidenenaphto[2,3-b]furan-6-yl (6S,2E,4E)-6-methylocta-2,4-dienoate
3-alpha,12-alpha-scilliphaeosidin|3-??,12??-Scilliphaeosidin
20beta,21beta-epoxy-resibufogenin|20S,21-Epoxyresibufogenin
16-methoxy-1-propionyl-aspidospermidine-17,21-diol|16-methoxy-limaspermine|3-Methoxy-limaspermin
kopsifoline B|methyl (1S,4R,5R,13R,19S,20S)-5,19-dihydroxy-8-methoxy-6,16-diazahexacyclo[11.6.1.11.4.05.13.07.12.016.20]henicosa-7(12),8,10-triene-4-carboxylate
4--3-hydroxy-5-methoxy-phthalaldehyd (Asperugon)|Asperugin|Asperugin B
fukanedone B|rel-3(S)-(2,4-dihydroxybenzoyl)-4(R),5(S)-dimethyl-5-[4,8-dimethyl-3(E)-7-nonadien-1-yl]tetrahydro-2-furanone
1alpha,6beta-dihydroxy-5,10-bis-epi-eudesm-4(15)-ene-6-O-beta-D-glucopyranoside|funingensin A
7-drimen-3beta-,11-diol 3-O-beta-D-glucopyranoside
(10alpha,15beta)-15-(but-3-enoyloxy)-6-oxokaur-16-en-18-oic acid|blepharispin B
3alpha-hydroxypatchoulol 3-O-beta-D-glucopyranoside
(2R*,5S*,7R*,10S*)-7-hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane
(+)-2R,7R,15R,17S,19S-10-demethoxy-12-hydroxy-17,19-epoxygeissovelline|10-demethoxy-12-hydroxy-17,19-epoxygeissovelline
1beta-hydroxy-3-oxo-4beta,5alpha,7alpha-H-eudesmane 11-O-alpha-L-rhamnopyranoside
2,7,11-trihydroxybisabola-1(15),9-diene 7-beta-D-fucopyranoside
2,7,10-trihydroxybisabola-1(15),11-diene 7-beta-D-fucopyranoside
3beta-hydroxy-4,4,14alpha-trimethyl-7,11,15,20-tetraoxo-pregn-8-en|lucidone D
(5S,6E)-5-beta-D-glucopyranosyloxy-3-hydroxy-3,7,11-trimethyldodeca-1,6,10-triene|amarantholidoside III
3beta,11-dihydroxy-drim-8(12)-en-3-O-beta-D-glucopyranoside|xianglinmaojueside B
1beta-(beta-D-glucopyranosyl)oxy-6alpha-hydroxyeudesman-4(15)-ene|1??-D-Glucopyranosyloxy-6??-hydroxyeudesman-4(15)-ene
1(R),4beta-dihydroxy-trans-eudesm-7-ene-1-O-beta-D-glucopyranoside|oplodiol 1-O-beta-D-glucopyranoside
11,14-dihydroxy-drim-8(12)-en-11-O-beta-D-glucopyranoside|xianglinmaojueside C
12beta-hydroxyl resibufogenin|12beta-hydroxyresibufogenin|12??-Hydroxyresibufogenin
phenyl-acetic acid 9-hydroxymethyl-7-(6-oxo-piperidin-2-yl)-octahydro-quinolizin-2-yl ester
6alpha,15beta-diacetoxy-ent-kaura-9(11),16-dien-12-one
(6Z,9R,10E,12Z,15Z)-1-(2,4,6-trihydroxyphenyl)-9-hydroxyoctadeca-6,10,12,15-tetraen-1-one
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid
7-[(2,6-dihydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl)methoxy]chromen-2-one
7-[(2,6-dihydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl)methoxy]chromen-2-one
C22H28N2O5_Methyl (16Z)-9-hydroxy-16-(methoxymethylene)-2-oxocorynoxan-17-oate
C24H32O5_2-Propenoic acid, 3-phenyl-, 10-hydroxy-1,6-dimethyl-9-(1-methylethyl)-5,12-dioxatricyclo[9.1.0.0~4,6~]dodec-8-yl ester, (2E)
7-[(2,6-dihydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl)methoxy]chromen-2-one [IIN-based on: CCMSLIB00000847022]
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000846078]
7-[(2,6-dihydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl)methoxy]chromen-2-one [IIN-based: Match]
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based: Match]
Ala Ile Pro Thr
Ala Ile Thr Pro
Ala Leu Pro Thr
Ala Leu Thr Pro
Ala Pro Ile Thr
Ala Pro Leu Thr
Ala Pro Thr Ile
Ala Pro Thr Leu
Ala Thr Ile Pro
Ala Thr Leu Pro
Ala Thr Pro Ile
Ala Thr Pro Leu
Ile Ala Pro Thr
Ile Ala Thr Pro
Ile Pro Ala Thr
Ile Pro Thr Ala
Ile Thr Ala Pro
Ile Thr Pro Ala
Leu Ala Pro Thr
Leu Ala Thr Pro
Leu Pro Ala Thr
Leu Pro Thr Ala
Leu Thr Ala Pro
Leu Thr Pro Ala
Pro Ala Ile Thr
Pro Ala Leu Thr
Pro Ala Thr Ile
Pro Ala Thr Leu
Pro Ile Ala Thr
Pro Ile Thr Ala
Pro Leu Ala Thr
Pro Leu Thr Ala
Pro Ser Val Val
Pro Thr Ala Ile
Pro Thr Ala Leu
Pro Thr Ile Ala
Pro Thr Leu Ala
Pro Val Ser Val
Pro Val Val Ser
Ser Pro Val Val
Ser Val Pro Val
Ser Val Val Pro
Thr Ala Ile Pro
Thr Ala Leu Pro
Thr Ala Pro Ile
Thr Ala Pro Leu
Thr Ile Ala Pro
Thr Ile Pro Ala
Thr Leu Ala Pro
Thr Leu Pro Ala
Thr Pro Ala Ile
Thr Pro Ala Leu
Thr Pro Ile Ala
Thr Pro Leu Ala
Val Pro Ser Val
Val Pro Val Ser
Val Ser Pro Val
Val Ser Val Pro
Val Val Pro Ser
Val Val Ser Pro
Lucidone B
Berkeleylactone G
Berkeleylactone H
9-Hydroxy-1-(2,4,6-trihydroxyphenyl)-6Z,10E,12Z,15Z-octadecatetraen-1-one
2,2,2,2-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetamide
Pyrrolo3,4-cpyrrole-1,4-dione, 3,6-bis4-(1,1-dimethylethyl)phenyl-2,5-dihydro
(6S)-3-[[4-[(2E)-3,7-dimethylocta-2,6-dienoxy]phenyl]methylidene]-1,4-dihydroxy-6-methyl-piperazine-2,5-dione
ethyl prop-2-enoate,2-methylidenehexanoic acid,methyl 2-methylprop-2-enoate,prop-2-enoic acid
Tiocarlide
J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis > J04AD - Thiocarbamide derivatives D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent
5-[4-(Dimethylamino)phenyl]-6-[(6-Morpholin-4-Ylpyridin-3-Yl)ethynyl]pyrimidin-4-Amine
2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide
N-[3-[6-(3-pyrrolidin-1-ylpropylamino)pyridin-3-yl]phenyl]benzamide
18-Hydroxy-11,17-dimethoxyyohimban-16-carboxylic acid
5,7-dihydroxy-6-(3-methylbut-2-enyl)-8-(3-methylbutanoyl)-4-pentyl-2H-chromen-2-one
A natural product found in Mammea americana.
2H-1-Benzopyran-2-one, 7-[[(1R,2S,4aS,6S,8aR)-decahydro-2,6-dihydroxy-2,5,5,8a-tetramethyl-1-naphthalenyl]methoxy]-
Rapivab
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AH - Neuraminidase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D004791 - Enzyme Inhibitors
Amantadine sulfate
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent C93038 - Cation Channel Blocker
(10-hydroxy-1,6-dimethyl-9-propan-2-yl-5,12-dioxatricyclo[9.1.0.04,6]dodecan-8-yl) (E)-3-phenylprop-2-enoate
Ala-Leu-Thr-Pro
A tetrapeptide composed of L-alanine, L-leucine, L-threonine, and L-proline units joined in sequence.
1-cyclopentyl-1-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-3-(2-oxolanylmethyl)thiourea
2,4-dioxo-3-pentyl-N-[3-(1-piperidinyl)propyl]-1H-quinazoline-7-carboxamide
rel-(2R,5S,7R,10S)-7-Hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane
A natural product found in Carthamus oxyacantha.
(1S,5R)-3-[(3-methoxyphenyl)methyl]-7-[4-(4-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
(1R,5S)-7-[4-(4-cyanophenyl)phenyl]-N-cyclohexyl-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
1-tert-butyl-3-(2,6-diisopropyl-4-phenoxyphenyl)thiourea-S-oxide
2,3-Dihydroxypropyl (2-hydroxy-3-undecoxypropyl) hydrogen phosphate
Marinobufogenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D004791 - Enzyme Inhibitors
7alpha-Hydroxy-3,12-dioxochola-1,4-dien-24-oic Acid
2-[(5-hydroxy-2-isopropyl-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2r)-2-[(2r,5s)-5-[(2s)-2-{[(2s)-2-[(2s,5r)-5-[(2r)-2-hydroxypropyl]oxolan-2-yl]propanoyl]oxy}butyl]oxolan-2-yl]propanoic acid
methyl 2-[2,5-dihydroxy-4-(3,7,11-trimethyl-9-oxododeca-2,6,10-trien-1-yl)phenyl]acetate
methyl (1r,10r,12s,19s)-12-ethyl-4,10-dihydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,8-tetraene-10-carboxylate
1-[(4s,12s,13r,16r,17s,18r,20r)-9,20-dihydroxy-8-methoxy-16-methyl-15-oxa-1,11-diazahexacyclo[15.3.1.0⁴,¹².0⁴,²⁰.0⁵,¹⁰.0¹³,¹⁸]henicosa-5,7,9-trien-11-yl]ethanone
methyl (1s,15r,16s,18r,19r,20s)-18-hydroxy-7-methoxy-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
(2s,3r,4s,5r,6r)-2-({2-[(2r,5r,7r,10r)-7-hydroperoxy-10-methyl-6-methylidenespiro[4.5]decan-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol
7-{[(2e,6e,10s)-10,11-dihydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl]oxy}chromen-2-one
(1r,8s)-4-(acetyloxy)-5-isopropyl-11,11-dimethyl-16-oxatetracyclo[6.6.2.0¹,¹⁰.0²,⁷]hexadeca-2,4,6-trien-3-yl acetate
(3e,6s)-3-[(4-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}phenyl)methylidene]-1,4-dihydroxy-6-methylpiperazine-2,5-dione
[(2r,3s,4s,5r,6r)-5-(acetyloxy)-3,4-dihydroxy-6-[(7-methyl-3-methylideneoct-6-en-1-yl)oxy]oxan-2-yl]methyl acetate
2-(hydroxymethyl)-6-{[5-(hydroxymethyl)-1,1,4a-trimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl]oxy}oxane-3,4,5-triol
(3br,4s,5r,5ar,9ar,9br,11as)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-2,7-dioxo-1h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
7-{[(2e)-5-[(1r,3r,6s)-3,6-dihydroxy-2,2,6-trimethylcyclohexyl]-3-methylpent-2-en-1-yl]oxy}chromen-2-one
(3br,4s,5r,5as,9ar,9br,11as)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-2,7-dioxo-1h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(2r,3r,4s,5r,6r)-2-{[(1s,4s,4as,8as)-4-hydroxy-4,8a-dimethyl-6-(propan-2-ylidene)-hexahydro-1h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(3e,5r,8s,11e,13r,16s)-5,13-dihydroxy-8,16-bis[(2s)-2-hydroxypropyl]-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione
7-{[(1r,2s,4ar,6s,8as)-2,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]methoxy}chromen-2-one
(2r)-2-[(2r,5s)-5-[(2s)-2-{[(2s)-2-[(2s,5r)-5-[(2r)-2-hydroxybutyl]oxolan-2-yl]propanoyl]oxy}propyl]oxolan-2-yl]propanoic acid
methyl (2z)-2-[(3r,6's,7'r,8'as)-6'-ethyl-2,4-dihydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl]-3-methoxyprop-2-enoate
(3r,3as,3bs,7ar,8s,8as)-3-hydroxy-3b,4,4,7a-tetramethyl-octahydroindeno[1,2-c]furan-8-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
10-hydroxy-9-isopropyl-1,6-dimethyl-5,12-dioxatricyclo[9.1.0.0⁴,⁶]dodecan-8-yl 3-phenylprop-2-enoate
(2r,3r,4s,5s,6r)-2-{[(1ar,3as,4s,7s,7as,7br)-7-hydroxy-1,1,3a,7-tetramethyl-octahydrocyclopropa[a]naphthalen-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
7-{[(1s,2r,4ar,6s,8ar)-2,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]methoxy}chromen-2-one
(2s,3r,4s,5s,6r)-2-{[(1s,4s,4as,8as)-4-hydroxy-1,4a-dimethyl-7-(propan-2-ylidene)-hexahydro-2h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5r,6r)-2-{[(1s,4s,4as,8as)-4-hydroxy-1,4a-dimethyl-7-(propan-2-ylidene)-hexahydro-2h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (1r,9r,10s,11r,12r,19r)-12-ethyl-5,10,11-trihydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-10-carboxylate
12β-hydroxyresibufogenin
{"Ingredient_id": "HBIN000759","Ingredient_name": "12\u03b2-hydroxyresibufogenin","Alias": "NA","Ingredient_formula": "C24H32O5","Ingredient_Smile": "CC12CCC(CC1CCC3C2CC(C4(C35C(O5)CC4C6=COC(=O)C=C6)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10671","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1β-d-glucopyranosyloxy-6α-hydroxy-eudesman-4(15)-ene
{"Ingredient_id": "HBIN002393","Ingredient_name": "1\u03b2-d-glucopyranosyloxy-6\u03b1-hydroxy-eudesman-4(15)-ene","Alias": "NA","Ingredient_formula": "C21H36O7","Ingredient_Smile": "CC(C)C1CCC2(C(CCC(=C)C2C1O)OC3C(C(C(C(O3)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8691","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
20r,21-epoxyresibufogenin
{"Ingredient_id": "HBIN003437","Ingredient_name": "20r,21-epoxyresibufogenin","Alias": "NA","Ingredient_formula": "C24H32O5","Ingredient_Smile": "CC12CCC(CC1CCC3C2CCC4(C35C(O5)CC4C67C=CC(=O)OC6O7)C)O","Ingredient_weight": "400.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7191","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10092398","DrugBank_id": "NA"}
20s,21-epoxyresibufogenin
{"Ingredient_id": "HBIN003471","Ingredient_name": "20s,21-epoxyresibufogenin","Alias": "NA","Ingredient_formula": "C24H32O5","Ingredient_Smile": "CC12CCC(CC1CCC3C2CCC4(C35C(O5)CC4C67C=CC(=O)OC6O7)C)O","Ingredient_weight": "400.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7192","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10453620","DrugBank_id": "NA"}
3-α,12α-scilliphaeosidin
{"Ingredient_id": "HBIN007894","Ingredient_name": "3-\u03b1,12\u03b1-scilliphaeosidin","Alias": "NA","Ingredient_formula": "C24H32O5","Ingredient_Smile": "CC12CCC(C=C1CCC3C2CC(C4(C3(CCC4C5=COC(=O)C=C5)O)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "19512","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
atractyloside c
{"Ingredient_id": "HBIN017303","Ingredient_name": "atractyloside c","Alias": "NA","Ingredient_formula": "C21H36O7","Ingredient_Smile": "CC12CCC(CC1C(=C)CC(C2)O)C(C)(C)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "400.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14420","TCMID_id": "1976","TCMSP_id": "NA","TCM_ID_id": "6491","PubChem_id": "101831401","DrugBank_id": "NA"}